Skip to content
sellWeak10b5-1 plan

BENKOWITZ MICHAEL sold $3.5M of UTHR

PRESIDENT AND COO at UNITED THERAPEUTICS Corp. 10,000 shares at an average of $353.64, traded Feb 3, 2025, filed Feb 4, 2025.

Warning score
30
Value
$3.5M
10,000 shares
Holdings after
0
-133% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001562180-25-000883, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 3, 2025MOption exercise
Common Stockindirect: by Trust10b5-1
+7,500$111.00$833k7,500Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-600$347.32$208k6,900Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-200$348.64$70k6,700Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-418$350.37$146k6,282Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-652$351.32$229k5,630Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-1,121$352.37$395k4,509Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-500$353.30$177k4,009Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-1,005$354.80$357k3,004Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-1,204$355.63$428k1,800Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-1,600$356.81$571k200Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-200$358.08$72k0Feb 4, 2025
Feb 3, 2025MOption exercise
Common Stockindirect: by Trust10b5-1
+2,500$111.00$278k2,500Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-200$347.05$69k2,300Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-100$348.61$35k2,200Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-100$350.05$35k2,100Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-400$351.79$141k1,700Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-400$353.13$141k1,300Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-400$354.69$142k900Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-400$355.58$142k500Feb 4, 2025
Feb 3, 2025SOpen-market sale
Common Stockindirect: by Trust10b5-1
-500$357.01$179k0Feb 4, 2025
Feb 3, 2025MOption exercise
Stock Optionderivativeindirect: by Trust10b5-1
-2,500$0.00$012,000Feb 4, 2025
Feb 3, 2025MOption exercise
Stock Optionsderivativeindirect: by Trust10b5-1
-7,500$0.00$029,679Feb 4, 2025

Related signals

Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
25Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$640k2,000
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.0M9,679
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.6M10,000
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.7M10,000
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.5M10,000
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.7M10,000
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.6M10,000
38Weaksell 210b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.6M10,000
38Weaksell 210b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.6M10,000
45Moderatesell 310b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.6M10,000

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

BENKOWITZ MICHAEL sold $3.5M of UTHR | InsiderTell